ABIT:XETRA:XETRA-AXA IM ACT Biodiversity Equity UCITS ETF - USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 11.654

Change

+0.01 (+0.07)%

Market Cap

N/A

Volume

84.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

ETFs Containing ABIT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.54% 34% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.54% 39% F 37% F
Trailing 12 Months  
Capital Gain 3.52% 42% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.52% 45% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.95% 58% F 59% D-
Dividend Return 7.95% 57% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.34% 64% D 72% C
Risk Adjusted Return 85.17% 75% C 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike